Technology advances for bioanalysis and metabolite identification

It’s critical to plan DMPK investments strategically to meet all of today's and tomorrow's needs – and laboratories are facing exciting opportunities and significant challenges as organizations reinvigorate their drug product pipelines. Now is a good time to think about the future.

Is your DMPK laboratory fit for the future?
There is a continuing need for sensitive, reliable, and faster systems for DMPK or ADME studies. But what if you could couple these features with solutions that simplify sample workup, that make regulatory compliance not only simple but also a valuable tool for your organization. What if technology could revolutionize reporting and collaboration, while still providing the high quality kinetic and structural data required to make the critical decisions in DMPK and throughout the drug development process?

• While MS sensitivity has advanced, analytical software needs to take a giant step forward.
• DMPK researchers need adaptive workflows that enable them to function as a unified team.
• Sample preparation methodology is critical to achieve purity, consistency, and quality.
• Peptide and protein analyses aren’t tomorrow’s goals – they’re today’s needs.
• Better tools are needed to address the ever-increasing reach of regulatory demands.